These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8852494)

  • 1. Complement C4 phenotypes in patients with end-stage renal disease.
    Lhotta K; Schlögl A; Uring-Lambert B; Kronenberg F; König P
    Nephron; 1996; 72(3):442-6. PubMed ID: 8852494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C4 uremic variant: an acquired C4 allotype.
    Welch TR; Beischel L
    Immunogenetics; 1985; 22(6):553-62. PubMed ID: 3865892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C4 and Bf phenotypes in black and Caucasian patients with childhood onset insulin dependent diabetes mellitus.
    Wang C; Rivas ML; Burghen GA; Hudson EC; Wyatt RJ
    J Clin Lab Immunol; 1989 Dec; 30(4):183-90. PubMed ID: 2642174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphism of complement C4 and susceptibility to IDDM and microvascular complications.
    Lhotta K; Auinger M; Kronenberg F; Irsigler K; König P
    Diabetes Care; 1996 Jan; 19(1):53-5. PubMed ID: 8720534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene and haplotype frequencies of the fourth component of complement (C4) in type 1 diabetics and normal controls.
    Bertrams J; Hintzen U; Schlicht V; Schoeps S; Gries FA; Louton TK; Baur MP
    Immunobiology; 1984 May; 166(4-5):335-44. PubMed ID: 6480029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional properties of heterogeneous human asialo-C4 and its isotypes C4A and C4B.
    Schultz DR; Arnold PI
    Immunobiology; 1992 Jun; 185(1):90-102. PubMed ID: 1398744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphism of the C4 component of human complement in the Slovak population.
    Staneková D; Starsia Z; Valúch J
    Folia Biol (Praha); 1991; 37(3-4):156-63. PubMed ID: 1822442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C4 phenotypes in IgA nephropathy: disease progression associated with C4A deficiency but not with C4 isotype concentrations.
    Wopenka U; Thysell H; Sjöholm AG; Truedsson L
    Clin Nephrol; 1996 Mar; 45(3):141-5. PubMed ID: 8706353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fluid-phase binding of human C4 and its genetic variants, C4A3 and C4B1, to immunoglobulins.
    Kishore N; Shah D; Skanes VM; Levine RP
    Mol Immunol; 1988 Sep; 25(9):811-9. PubMed ID: 3264881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the metabolism of C4 isotypes in patients with complement activation.
    Peake PW; Pussell BA; Charlesworth JA; Gavrilovic L; Timmermans V
    Clin Exp Immunol; 1989 Oct; 78(1):49-53. PubMed ID: 2530015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative electrophoretic migration distances for the classification of C4 allotypes.
    Mauff G; Brenden M; Braun-Stilwell M
    Complement Inflamm; 1990; 7(4-6):277-81. PubMed ID: 2088666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glomerular deposition of the complement C4 isotypes C4A and C4B in glomeruonephritis.
    Lhotta K; Schlogl A; Kronenberg F; Joannidis M; Konig P
    Nephrol Dial Transplant; 1996 Jun; 11(6):1024-8. PubMed ID: 8671963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major histocompatibility complex haplotypes and complement C4 alleles in systemic lupus erythematosus. Results of a multicenter study.
    Hartung K; Baur MP; Coldewey R; Fricke M; Kalden JR; Lakomek HJ; Peter HH; Schendel D; Schneider PM; Seuchter SA
    J Clin Invest; 1992 Oct; 90(4):1346-51. PubMed ID: 1401069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement phenotypes in glomerulonephritis: increased frequency of homozygous null C4 phenotypes in IgA nephropathy and Henoch-Schönlein purpura.
    McLean RH; Wyatt RJ; Julian BA
    Kidney Int; 1984 Dec; 26(6):855-60. PubMed ID: 6533396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentrations of C4 isotypes and factor B in type I C2 deficiency suggest haplotype-dependent quantitative expression of MHC class III complement genes.
    Truedsson L; Gullstrand B; Jönsson T; Klint C
    Exp Clin Immunogenet; 1995; 12(2):66-73. PubMed ID: 7576717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High resolution electrophoresis for the allotyping of human C4. Proposal of a relational nomenclature.
    Kölble K; Rukavina V; Kalden JR
    J Immunol Methods; 1987 Jan; 96(1):69-76. PubMed ID: 3492559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism of the fourth component of complement in Graves' disease and type I diabetes mellitus.
    Skanes V; Larsen B; Sampson-Murphy L; Farid NR
    Clin Invest Med; 1985; 8(2):126-32. PubMed ID: 3869086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
    Skanes VM; Barnard J; Farid N; Marshall WH; Murphy L; Rideout D; Taylor R; Xidos G; Larsen B
    Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA polymorphism of human HLA-linked complement C4 allotypes, including C4 null alleles, in the Finnish population.
    Partanen J; Peltonen L; Koskimies S; Carroll MC
    Hum Hered; 1987; 37(4):241-9. PubMed ID: 2888726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphism of the human complement component C4.
    Campbell RD; Dunham I; Kendall E; Sargent CA
    Exp Clin Immunogenet; 1990; 7(1):69-84. PubMed ID: 1971760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.